| 中文名 | 3'-氯-3'-脱氧-5'-O-三苯甲基胸苷 |
|---|---|
| 英文名 | 1-[(2R,4S,5R)-4-chloro-5-(trityloxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione |
| 英文别名 |
5'-O-trityl-3'-chlorothymidine
3'-Chlor-3'-desoxy-5'-O-tritylthymidin 3’-Chloro-3'-deoxy-5’-O-tritylthymidine 5’-O-Triphenylmethyl-3’-deoxy-3’-chlorothymidine 5’-O-Trityl-3’-deoxy-3’-chloro-5-methyluridine 2’,3’-Dideoxy-3’-chloro-5-methyl-5’-O-trityluridine 3'-Chloro-3'-deoxy-5'-O-(triphenylMethyl)thyMidine 3'-Chloro-3'-deoxy-5'-O-tritylthymidine 5'-O-Triphenylmethyl-3'-deoxy-3'-chlorothymidine 3'-chloro-O5'-trityl-3'-deoxy-thymidine Thymidine, 3'-chloro-3'-deoxy-5'-O-(triphenylmethyl) 5’-O-Trityl-2’,3’-dideoxy-3’-chloro-5-methyluridine 3'-Chloro-3'-deoxy-5'-O-(triphenylmethyl)thymidine |
| 描述 | 3′-氯-3′-脱氧-5′-O-(三苯基甲基)胸苷是嘌呤核苷类似物。嘌呤核苷类似物具有广泛的抗肿瘤活性,靶向惰性淋巴系统恶性肿瘤。这一过程中的抗癌机制依赖于抑制DNA合成、诱导细胞凋亡等[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C29H27ClN2O4 |
|---|---|
| 分子量 | 502.99 |
| 精确质量 | 502.16600 |
| PSA | 73.58000 |
| LogP | 5.16090 |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |